Emergo by UL sponsored a session in the Exhibit Hall (Sept. 18) titled Navigating and Managing the Global Regulatory Landscape: Strategic Approaches for Success during RAPS 2024. This is part of a series on RAPS.
Emergo by UL Human Factors Specialists discuss improving patient engagement through gamification.
Consider use-related risk analysis in simple terms, so that you can start early and use it as a powerful tool for creative output.
Emergo by UL human factors specialists share a checklist that is convenient when one is preparing for and participating in meetings with the U.S. FDA regarding human factors strategy.
MHRA, the UK medical device regulator, gave a progress report on the agency's work toward completing its roadmap of medical device legislation.
U.S. regulator no longer accepting animal testing data from two Chinese labs to support premarket applications
In this on-demand webinar, our Emergo by UL expert shares insights on importer/distributor MDR requirements and impacts for manufacturers.
The U.S. FDA has finalized its 2022 draft guidance document Voluntary Malfunction Summary Reporting (VMSR) Program for Manufacturers.
Returning from a long holiday and need to catch up on EU medical device and IVD regulatory developments? Read our update on European regulatory news over the last few months.
This article explores the current landscape of how older adult users might interact with technology, particularly those in the healthcare space.